"Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer

Gynecologic Oncology

Volumn 116, Issue 3, 2010, Pages 370-373

  Zighelboim, Israel ^a   Kizer, Nora ^a   Taylor, Nicholas P ^b   Case, Ashley S ^c   Gao, Feng ^d   Thaker, Premal H ^a   Rader, Janet S ^a   Massad, L Stewart ^a   Mutch, David G ^a   Powell, Matthew A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^c Hope A Women's Cancer Center   (United States)

^d USA   (United States)

Author keywords

Apgar; Cytoreduction; Debulking; Morbidity; Mortality; Ovarian cancer; Surgical score

Indexed keywords

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ADVANCED CANCER; AGED; APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CANCER STAGING; CANCER SURGERY; COMORBIDITY; CYTOREDUCTIVE SURGERY; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MEDICAL RECORD REVIEW; OPERATION DURATION; OVARY CANCER; PERITONEUM CANCER; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIMARY TUMOR; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; SEPSIS; SURGICAL APGAR SCORE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UTERINE TUBE CARCINOMA; VENOUS THROMBOEMBOLISM; WOUND DEHISCENCE;

FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT;

EID: 75749100537     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.11.031     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics, 2009. CA. Cancer J. Clin. 59 (2009) 225-249
2. In: Ries L.A.G., Krapcho M., Stinchcomb D.G., Howlader N., Horner M.J., Mariotto A., et al. (Eds). SEER Cancer Statistics Review, 1975-2005 (2008), Cancer Institute, Bethesda, MD
3. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J. Clin. Oncol. 20 (2002) 1248-1259
4. Chi D.S., Eisenhauer E.L., Zivanovic O., Sonoda Y., Abu-Rustum N.R., Levine D.A., et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol. Oncol. 114 (2009) 26-31
5. Winter III W.E., Maxwell G.L., Tian C., Sundborg M.J., Rose G.S., Rose P.G., et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group study. J. Clin. Oncol. 26 (2008) 83-89
6. Chi D.S., McCaughty K., Diaz J.P., Huh J., Schwabenbauer S., Hummer A.J., et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 106 (2006) 1933-1939
7. Eisenhauer E.L., Abu-Rustum N.R., Sonoda Y., Levine D.A., Poynor E.A., Aghajanian C., et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol. Oncol. 103 (2006) 1083-1090
8. Moore K.N., Reid M.S., Fong D.N., Myers T.K., Landrum L.M., Moxley K.M., et al. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?. Gynecol. Oncol. 110 (2008) 133-139
9. Eisenhauer E.L., Tew W.P., Levine D.A., Lichtman S.M., Brown C.L., Aghajanian C., et al. Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecol. Oncol. 106 (2007) 381-387
10. Gawande A.A., Kwaan M.R., Regenbogen S.E., Lipsitz S.A., and Zinner M.J. An Apgar score for surgery. J. Am. Coll. Surg. 204 (2007) 201-208
11. Stewart J.H., Bertoni A.G., Staten J.L., Levine E.A., and Gross C.P. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann. Surg. Oncol. 14 (2007) 3328-3334
12. Bristow R.E., Eisenhauer E.L., Santillan A., and Chi D.S. Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol. Oncol. 104 (2007) 480-490
13. Tetsche M.S., Dethlefsen C., Pedersen L., Sorensen H.T., and Norgaard M. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. BMC Cancer 8 (2008) 31
14. Janda M., Youlden D.R., Baade P.D., Jackson D., and Obermair A. Elderly patients with stage III or IV ovarian cancer: should they receive standard care?. Int. J. Gynecol. Cancer 18 (2008) 896-907
15. Massad L.S., Vogler G., Herzog T.J., and Mutch D.G. Correlates of length of stay in gynecologic oncology patients undergoing inpatient surgery. Gynecol. Oncol. 51 (1993) 214-218
16. Regenbogen S.E., Ehrenfeld J.M., Lipsitz S.R., Greenberg C.C., Hutter M.M., and Gawande A.A. Utility of the surgical Apgar score: validation in 4119 patients. Arch. Surg. 144 (2009) 30-36 discussion 37
17. Van Le L., Fakhry S., Walton L.A., Moore D.H., Fowler W.C., and Rutledge R. Use of the APACHE II scoring system to determine mortality of gynecologic oncology patients in the intensive care unit. Obstet. Gynecol. 85 (1995) 53-56
18. Aletti G.D., Santillan A., Eisenhauer E.L., Hu J., Aletti G., Podratz K.C., et al. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecol. Oncol. 107 (2007) 99-106
19. Aletti G.D., Dowdy S.C., Podratz K.C., and Cliby W.A. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am. J. Obstet. Gynecol. 197 676 (2007) e1-e7
20. Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope R.C., Wilson T.O., et al. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. J. Am. Coll. Surg. 208 (2009) 614-620
21. Regenbogen S.E., Lancaster R.T., Lipsitz S.R., Greenberg C.C., Hutter M.M., and Gawande A.A. Does the Surgical Apgar Score measure intraoperative performance?. Ann. Surg. 248 (2008) 320-328
22. Kondalsamy-Chennakesavan S., Bouman C., De Jong S., Sanday K., Nicklin J., Land R., et al. Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events. Gynecol. Oncol. 115 (2009) 329-333